📊 Isolated degenerative MVr: 82 reops over 30 years
📊 Isolated degenerative MVr: 82 reops over 30 years
In a single-center cohort of 1,222 patients undergoing isolated degenerative mitral valve repair (MVr) from 1991–2024, only 82 required reoperation for recurrent mitral regurgitation (6.7%)—and reoperation did not worsen long-term survival. The study found residual MR at discharge was the principal determinant of later repair failure, and timely reoperation reduced cardiovascular morbidity.
Why It Matters To Your Practice
Sets expectations: recurrent MR requiring reoperation after isolated degenerative MVr was uncommon over >3 decades of follow-up (82/1,222; 6.7%).
Reinforces discharge echo importance: residual MR at discharge was the key signal for future failure.
Supports counseling: needing a reop, when appropriately timed, was not associated with worse long-term survival in this specialized program.
Clinical Benefits
Prioritizes actionable follow-up: patients with residual MR at discharge may warrant closer surveillance and earlier cardiology/cardiothoracic coordination.
Frames reoperation as stabilizing care: timely reintervention was associated with restored clinical stability and fewer cardiovascular morbidity events.
Helps risk communication: patients can be reassured that reoperation, when needed, may not imply shortened survival.
Managing Risks
Do not downplay residual MR: treat it as a high-value handoff item from inpatient to outpatient teams, including clear echo findings and follow-up timing.
Watch for recurrent MR consequences: monitor for symptoms/signs of volume overload and heart failure decompensation, and escalate promptly if clinical status changes.
Coordinate timely referral: earlier reassessment and surgical review may reduce downstream cardiovascular readmissions/morbidity.
The Bottom Line
Across 1,222 isolated degenerative MVr cases over 30+ years, reoperation for recurrent MR was infrequent (6.7%) and not linked to worse long-term survival.
Residual MR at discharge is the key determinant of later failure—make discharge echo results drive follow-up intensity and referral urgency.